# S-Kap Unternehmensbeteiligungs

> S-Kap Unternehmensbeteiligungs is a VC fund backing Software and Artificial Intelligence. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Pforzheim, Germany
- Total investments: 7
- Last investment: Mar 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.s-kap.de

S-Kap Unternehmensbeteiligungs is a VC fund in Pforzheim focused on Software and Artificial Intelligence. S-Cape Beteiligungsgesellschaft is a private equity firm offering financing to startups and entrepreneurs seeking an investment.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 43% |
| Artificial Intelligence | 2 | 29% |
| SaaS | 1 | 14% |
| Marketing | 1 | 14% |
| E-Commerce | 1 | 14% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 29% |
| Series B | 2 | 29% |
| Series C | 1 | 14% |
| Funding Round | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 4 | 57% |
| United States | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Deep Care | Deep Care is an intelligent seat behavior assistant that offers sitting behavior for office workers. |  | Seed | Mar 06, 2024 |  |
| gyde | Gyde offers digital micro-learning and cross-company coaching for managers. Gyde builds a fully digital talent development solution that enables employees to learn through app-based microlearning and peer coaching sessions. They connect employees with peers from other companies to foster a steep learning curve through social learning. | $1.1M | Seed | Aug 05, 2022 |  |
| Deep Care | Deep Care is an intelligent seat behavior assistant that offers sitting behavior for office workers. |  | Seed | Mar 18, 2022 |  |
| BrandMaker | BrandMaker is the software provider for effective Marketing Resource Management (MRM). The company gives enterprise marketers the visibility and control to optimize their marketing operations. The enterprise-level MRM solution turns marketing into a business-building powerhouse by letting marketing leaders get on top of their budgets, peopleworkflows, campaigns, and marketplace performance. BrandMaker is made to tame the complexity of multinational marketing. With our European roots, equipping companies to work across borders, cultures, and silos comes naturally to us. Accordingly, Forrester and Gartner recognize BrandMaker as a leader in MRM. More than 300 leading companies including Bayer, Daimler and Avantor trust in our solutions to increase their effectiveness in marketing planning and execution. |  | Series C | Jun 27, 2018 |  |
| BrandMaker | BrandMaker is the software provider for effective Marketing Resource Management (MRM). The company gives enterprise marketers the visibility and control to optimize their marketing operations. The enterprise-level MRM solution turns marketing into a business-building powerhouse by letting marketing leaders get on top of their budgets, peopleworkflows, campaigns, and marketplace performance. BrandMaker is made to tame the complexity of multinational marketing. With our European roots, equipping companies to work across borders, cultures, and silos comes naturally to us. Accordingly, Forrester and Gartner recognize BrandMaker as a leader in MRM. More than 300 leading companies including Bayer, Daimler and Avantor trust in our solutions to increase their effectiveness in marketing planning and execution. |  | Series B | Sep 25, 2017 |  |
| amcure | amcure is a privately held, clinical-stage company developing peptide-based compounds for the treatment of highly metastatic forms of squamous cancer. Established in 2012, amcure GmbH is a spin-off from the Karlsruhe Institute of Technology (KIT) and is supported by a grant from the German Federal Ministry of Education and Research. amcureleverages its in-depth knowledge of CD44 target biology to develop a novel therapeutic approach to treat metastatic squamous tumors. In cancer, blocking the extracellular target CD44v6 has a beneficial effect on several relevant receptor tyrosine kinase pathways. Their first-in-class CD44v6-inhibitor AMC303 entered clinical development in solid tumors in Q4 2016. | $6.6M | Series B | Dec 14, 2016 |  |
| Onventis | Onventis is develops cloud based e-procurement solutions for supplier relationship management and vendor managed procurement. It offers a portfolio of solutions, including TradeCore Buyer, an integrated cloud-based procurement platform for supplier management, sourcing, order management, and analytics; TradeCore Vendor, a sales tool for wholesalersof indirect goods that include integrated order management, mobile ordering and approval options, catalog management, and reliable analysis functions; and TradeCore Provider, a multi-client solution for group procurement and collaborative commerce. |  |  | Jun 11, 2015 |  |

7 of 7 investments shown.

## Co-investors
- [eCAPITAL ENTREPRENEURIAL PARTNERS](https://shizune.co/investors/profile/ecapital-entrepreneurial-partners-ag) — VC Fund, 2 deals together
- [ES KAPITAL](https://shizune.co/investors/profile/es-kapital) — VC Fund, 2 deals together
- [Bar Tiger Wolf](https://shizune.co/investors/profile/bar-tiger-wolf) — VC Fund, 1 deal together
- [d.ventures](https://shizune.co/investors/profile/d-ventures) — VC Fund, 1 deal together
- [HeidelbergCapital Private Equity](https://shizune.co/investors/profile/heidelberg-capital-private-equity) — VC Fund, 1 deal together
- [Karlsruhe Institute of Technology](https://shizune.co/investors/profile/karlsruhe-institute-of-technology) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does S-Kap Unternehmensbeteiligungs invest in?

S-Kap Unternehmensbeteiligungs invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series B stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did S-Kap Unternehmensbeteiligungs last invest?

The most recent investment recorded for S-Kap Unternehmensbeteiligungs closed in Mar 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co